Aurora Kinase Inhibitors in Head and Neck Cancer

Author(s): Guangying Qi, Jing Liu, Sisi Mi, Takaaki Tsunematsu, Shengjian Jin, Wenhua Shao, Tian Liu, Naozumi Ishimaru, Bo Tang*, Yasusei Kudo*.

Journal Name: Current Topics in Medicinal Chemistry

Volume 18 , Issue 3 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Aurora kinases are a group of serine/threonine kinases responsible for the regulation of mitosis. In recent years, with the increase in Aurora kinase-related research, the important role of Aurora kinases in tumorigenesis has been gradually recognized. Aurora kinases have been regarded as a new target for cancer therapy, resulting in the development of Aurora kinase inhibitors. The study and application of these small-molecule inhibitors, especially in combination with chemotherapy drugs, represent a new direction in cancer treatment. This paper reviews studies on Aurora kinases from recent years, including studies of their biological function, their relationship with tumor progression, and their inhibitors.

Keywords: Aurora kinases, Mitosis, Head and neck cancer, Aurora kinase inhibitor, Tumor, Biological function.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 18
ISSUE: 3
Year: 2018
Page: [199 - 213]
Pages: 15
DOI: 10.2174/1568026618666180112163741
Price: $58

Article Metrics

PDF: 28
HTML: 2